10th Jan 2007 13:05
Elsevier MDL has unveiled a significant upgrade to the MDL(R)Isentris(R) system for integrating information and softwareapplications into scientists' workflows. MDL Isentris 2.0 featureshundreds of new capabilities and demonstrable and meaningfulperformance improvements that give pharmaceutical, biotech and lifesciences organizations unequaled ability to improve R&D productivitythrough better data management, lowered cost of ownership, fasterworkflow processes and easier information access and reporting. £ "MDL Isentris 2.0 offers features, performance and potential wellbeyond MDL(R) ISIS, the industry standard for the past 15 years," saidLars Barfod, President and CEO of Elsevier MDL. £ "Unique new features such as a visual reaction planner offerscientists better day-to-day workflow support. Dramatic performanceimprovements strengthen the value of Isentris from small to globalmulti-site R&D labs. And standardized development tools make it easyfor organizations to customize systems to meet their needs. More andmore of our major customers are migrating to Isentris to capitalize onthese advantages." £ MDL software is used at virtually every major pharmaceuticalcompany, and at biotechnology, chemical and research institutionsaround the world. Following recent evaluations of Isentris 2.0,several more leading companies have purchased the new-generationsystem, bringing the number of top 30 Elsevier MDL customers that haveadopted Isentris to 15. £ Dr. Dominique Swinnen, a Senior Scientist at Serono who viewed aprerelease, commented: "Isentris 2.0 looks very promising. I wasreally impressed with how user-friendly it was and especially with thereaction planning functionality. The ability to explore precursorreaction steps and quickly build reaction plans looks very useful andcould save us a lot of time during our synthesis preparation." £ The Isentris 2.0 release features proven performance on databasesof over 5 million reactions and 20 million structures. Reaction fastsearch gives substantial performance improvements over previouscartridge-based search engines, up to 100 times faster in some cases.Isentris now offers up to 15 times faster browsing over wide areanetworks than ISIS, and allows scientists to load scientific data intoMicrosoft Excel as much as six times faster, and copy, paste and sortthe data twice as fast. Isentris can support hundreds of simultaneoususers on a single mid-sized server. £ Isentris lets scientists search multiple databases with a singlequery, save and reuse sophisticated searches and create personal dataviews without IT assistance. Scientists can find information faster,explore structure-activity relationships, collaborate, pursuehypotheses and gain insight for informed, intelligent decisions. £ For organizations, Isentris is designed to handle the massiveloads, diverse data types and pressure of global R&D networks, whileoffering higher ROI and lower IT costs. Pre-built developmentcomponents in Isentris enable IT groups to rapidly create customscientific applications using Microsoft .NET technology. IT groups canreduce support workloads by providing scientists with self-servicedata access and consistent, easy to learn applications. And integratedaccess to internal proprietary and commercial data sources offerssignificant workflow and efficiencies. £ For more information visit www.mdl.com. A whitepaper is availableon request. £ About Elsevier MDL £ Elsevier MDL provides informatics, database and workflow solutionsthat accelerate successful scientific R&D by improving the speed andquality of scientists' decision making. Researchers around the worlddepend on Elsevier MDL for innovative and reliable discoveryinformatics software solutions and services augmented by 400 Elsevierchemistry and life sciences journals and related products. For moreinformation, visit www.mdl.com. Elsevier is a world-leading publisherof scientific, technical and medical information products andservices. For more information, visit www.elsevier.com. Elsevier ispart of Reed Elsevier Group plc, a world-leading publisher andinformation provider. Reed Elsevier's ticker symbols are REN (EuronextAmsterdam), REL (London Stock Exchange), RUK and ENL (New York StockExchange). For more information, visit www.reedelsevier.com. £ MDL and Isentris are registered trademarks of MDL InformationSystems, Inc. ('Elsevier MDL') in the United States. All rightsreserved. All other trademarks mentioned in this document are theproperty of their respective owners. Copyright Business Wire 2007Related Shares:
Relx